Verified employee & interview reviews

Pfizer India Reviews

Mumbai, Maharashtra

4.5/ 5

2 reviews

Pfizer in India, primarily operating through its publicly listed entity Pfizer Limited alongside Pfizer Products India Private Limited and Pfizer Healthcare India Private Limited, is one of the country's leading multinational pharmaceutical organizations. Established in 1950, the company has built a rich heritage spanning over seven decades, aligning its growth closely with India's healthcare landscape. Headquartered in Mumbai, Maharashtra, at the Bandra Kurla Complex, the company has expanded its footprint to become one of the largest multinational pharmaceutical manufacturers in the nation, serving millions of patients and consumers through a robust commercial and production network. The core operations of Pfizer India revolve around the manufacturing, marketing, trading, and distribution of a diverse portfolio of pharmaceutical products. Its expert therapeutic solutions are broadly categorized into major business segments including Vaccines, Oncology, Internal Medicine, Rare Diseases, Hospitals, and Inflammation and Immunology. The company boasts a comprehensive product portfolio containing over 150 products across 16 distinct therapeutic areas. Among its highly recognized brands in the Indian market are Prevenar 13, Corex-DX, Dolonex, Enbrel, Becosules, Gelusil, and Folvite. To support its massive commercial distribution, Pfizer's infrastructure in India includes three state-of-the-art manufacturing plants, two research and development centers, and six regional offices dedicated to commercial operations and global support functions. Its manufacturing capabilities are substantial, collectively producing approximately 4.5 billion units of medicines annually. Notable facilities include an award-winning manufacturing unit in Goa, which produces more than one billion tablets each year, and the Vizag manufacturing plant located in Andhra Pradesh. Additionally, its research capabilities are anchored by entities like the Global Drug Development Center situated at the IIT Madras Research Park in Chennai. This infrastructure allows the company to cater heavily to the domestic market while also exporting essential medicines to over 50 countries worldwide. Financially, Pfizer Limited has been listed on the Indian stock exchanges since 1966, trading on the Bombay Stock Exchange and the National Stock Exchange under the ticker PFIZER. The company has a widespread investor base exceeding one lakh shareholders. For the fiscal year ending March 31, 2025, Pfizer Limited generated a consolidated revenue from operations of INR 2,450 crore. Collectively, the various legal entities of Pfizer in India employ more than 5,500 professionals spanning manufacturing, research, and corporate roles. Under the leadership of Managing Director and CEO Meenakshi Nevatia, the company remains dedicated to delivering breakthrough therapies and maintaining a vigilant system of quality control across its operations.